An intestinal dysbacteriosis as a side-effect of anti-helicobacter therapy
Abstract
After anti-Helicobacter therapy 55 patients with duodenal ulcer and clinical signs of intestinal dysbacteriosis were under observation. We examined microbe spectrum of intestine before and after treatment by Colibacterin and Biofl orum. And the effectiveness of these medicines have compared. As a result of therapy by Colibacterin and Bioflorum, the reduction of clinical and microbiological signs of intestinal dysbacteriosis in two groups are remarked. There was detected the effectiveness of Bioflorum by the period of reduction of clinical signs and recovery of large intestine’ microflora. So, we recommend Bioflorum in the complex therapy under the control of microbial spectrum to the patients with duodenal ulcer.
About the Authors
L. A. Omarova
JSC «Astana Medical University»
Kazakhstan
Kazakhstan
Liliya Amirzhanovna Omarova, assistant of the chair of internal diseases
48/1–6, Zheltoksan str., Astana, 010000
T. R. Omarov
JSC «Astana Medical University»
Kazakhstan
Kazakhstan
MD, lecturer
References
1. Khavkin A.I., Zhikhareva N.S. Antibiotic therapy of dysbiosis // Gastroenterol. Consilium medicum. 2006; 2: 72–74.
2. Lionetti E., Indrio F., Pavone L. et al. Role of probiotics in pediatric patients with Helicobacter pylori infection: a comprehensive review of the literature // Helicobacter. 2010; 15 (2): 79–87.
3. Camilleri M. Probiotics and irritable bowel syndrome: rationale, putative mechanisms, and evidence of clinical efficacy // J. Clin. Gastroenterol. 2006; 40(3): 264–269.
4. Chernin V.V., Chervinets V.M., Bondarenko V.M., Bazlov S.N. Peptic ulcer disease, chronic gastritis and esophagitis in the aspect of dysbiosis of esophagogastricduodenal zone. Tver. «Triada». 2004. 200 p.
5. Ushkalova E.A. The role of probiotics in gastroenterology // Farmatek. 2007; 6: 16–23.
6. Shchupelkova Yu.O. Antibiotic-associated diarrhea // Russky medicinsky zhurnal. 2007; 15(6): 1–6.
7. Bondarenko V.M., Matsulevich T.V. Intestinal dysbiosis as clinical and laboratory syndrome: state of the art. Guide for physicians. M. «GEOTAR-Media». 2007. 304 p.
8. Gracheva N.M., Bondarenko V.M. Probiotic drugs in the treatment and prevention of intestinal dysbiosis // Infektsionnye bolezni. 2004; 2(2): 53–58.
9. Bondarenko V.M., Vorobyev A.A. Dysbiosis and drugs with probiotic function // Zhurn. mikrobiol. 2004; 1: 84–92.
10. Lee Y.K., Mazmanian S.K. Has the microbiota played a critical role in the evolution of the adaptive immune system? // Science. 2010; 330: 1768–1773.
11. Sjogren Y.M., Tomicic S., Lundberg A. et al. Infl uence of early gut microbiota on the maturation of childhood mucosal and systemic immune responses // Clin. Exp. Allergy. 2009; 39(12): 1842–1851.
Review
Views:
241
Email this article 